Chemoimmunotherapy with Krestin in acute leukemia

The purpose of this study was to determine if immunotherapy with Krestin can prolong the durations of complete remission and survival. The patients were placed at random in the chemotherapy and chemoimmunotherapy groups. The median durations of complete remission and survival were longer in the chemoimmunotherapy group than in the chemotherapy group. The complete remission rate of the second induction was higher in the chemoimmunotherapy group than in the chemotherapy group. The cell-mediated immunity was somewhat enhanced in the chemoimmunotherapy group, while it was not enhanced in the chemotherapy group. These results suggested that Krestin administration for maintenance therapy was useful for prolongation of the durations of remission and survival time in patients with acute leukemia.

One thought on “Chemoimmunotherapy with Krestin in acute leukemia”

  1. – there are many other options aibalvale in the US.The real question is BETTER than chemo or radiation really better? I’m a Cancer survivor who owes his life to chemo and radiation therapy. It worked for me. Cancer Treatment Centers of America bases it’s advertising on providing the most and best therapy’s aibalvale for Cancer. I may be biased, being an American- but even so, the research I’ve done rates America’s treatments, drugs, and general procedures a healthy cut above the rest of the world. I guess my best advice based on my opinion- would be to go with the usual course of treatment prescribed , unless the prognosis or results were terminal.

Leave a Reply